OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
OrthoPediatrics Corp. (NASDAQ: KIDS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $42.00 price target on the stock.
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
OrthoPediatrics Corp. (NASDAQ: KIDS) had its price target lowered by analysts at Truist Financial Co. from $28.00 to $25.00. They now have a "hold" rating on the stock.